Pediatric nonalcoholic fatty liver disease

Area of Science:

• Hepatology
• Pediatric Gastroenterology
• Metabolic Disorders

Background:

• Nonalcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions characterized by fat accumulation in the liver.
• Nonalcoholic steatohepatitis (NASH), a progressive form of NAFLD, increases the risk of liver cirrhosis and cancer.
• NAFLD prevalence is rising in pediatric populations, paralleling the increase in childhood obesity.

Purpose of the Study:

• To review current concepts on the natural history, pathophysiology, and management of NAFLD in pediatric patients.
• To address the increasing prevalence and health implications of NAFLD in children.
• To discuss controversies in the diagnosis and treatment of pediatric NAFLD and NASH.

Main Methods:

• Literature review of current concepts regarding NAFLD in pediatric patients.
• Synthesis of information on natural history, pathophysiology, and management strategies.
• Discussion of diagnostic workup and treatment controversies.

Main Results:

• NAFLD is increasingly prevalent in children, linked to obesity.
• Pathophysiology involves insulin resistance, oxidative stress, and inflammation.
• Diagnostic and treatment approaches for pediatric NAFLD/NASH remain debated.

Conclusions:

• NAFLD is a significant and growing concern in pediatric health.
• Understanding the pathophysiology is crucial for developing effective interventions.
• Further research and consensus are needed for optimal management of pediatric NAFLD.